Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001382963-14-000041

Options or other derivatives

  • Director acquired 11,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gonyer David A · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-07-17 Grant or award : show line 1 in the form Stock Option (right to buy) +6,000 $5.60 2024-07-17 6,000 6,000 D
2014-07-17 Grant or award : show line 2 in the form Restricted Stock Units +5,500 5,500 5,500 D
Loading xslF345X03/edgar.xml…